BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera

  June 26, 2026

   · 

  5 min read
• Press Releases

  Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

  Live Presentation and Q&A: Tuesday, June 30, 2026 12 PM EDT

  June 26, 2026

   · 

  4 min read
• Press Releases

  Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection

  Management to host conference call at 8:00 AM Eastern time on Friday, June 26, 2026

  June 26, 2026

   · 

  28 min read
• Press Releases

  Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders

  June 26, 2026

   · 

  3 min read
• Press Releases

  OS Animal Health Announces Peer-Reviewed Publication of Clinical Trial Data for OST-HER2 Plus Palliative Radiation as Frontline Treatment in Canine Osteosarcoma

  June 26, 2026

   · 

  9 min read
• Press Releases

  Hemostemix Closes $360,000 First Tranche of Private Placement

  June 26, 2026

   · 

  8 min read
• 

  Duchenne muscular dystrophy

  Capricor thrown for another loop as FDA sets adcomm for DMD cardiomyopathy therapy

  The FDA plans to hold an advisory committee meeting to discuss Capricor Therapeutics’ application for deramiocel, which the agency rejected last July. The news surprised CEO Linda Marbán, who told BioSpace the FDA has not communicated any issues of concern with the company’s resubmitted application.

  June 26, 2026

   · 

  4 min read

   · 

  Heather McKenzie
• Press Releases

  TempraMed Signs Non-Binding LOI with National Distributor in Saudi Arabia

  Strategic Saudi partnership with Rawafed Health International Company targets one of the region’s largest diabetes and injectable-therapy markets, supported by leading healthcare infrastructure, pharmacy access in the region

  June 26, 2026

   · 

  8 min read
• Press Releases

  MustGrow Biologics Corp. Announces Results of Shareholder Meeting

  June 26, 2026

   · 

  4 min read
• Press Releases

  Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) 4Q26

  June 26, 2026

   · 

  1 min read